MIAX:NYSEMiami International Holdings, Inc. Analysis
Data as of 2026-07-08 - not real-time
$43.72
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Miami International Holdings (MIAX) is trading above its short‑term moving average while still lagging the medium‑term average, with momentum indicators turning mildly bullish and volume on the rise. The stock’s valuation appears stretched, as its price‑earnings multiple sits well above the sector norm and discounted cash‑flow analysis points to a lower intrinsic value. Fundamentally, the company is delivering solid top‑line growth, expanding market share—as evidenced by a record‑setting year‑to‑date contract volume—and maintaining healthy operating margins with very low leverage.
Recent product launches, such as the Bloomberg 100 Index Futures, and continued volume growth provide a compelling growth narrative, yet the elevated valuation and high recent volatility suggest caution. Investors should weigh the upside from market expansion against the risk of price correction given the overvalued metrics.
Recent product launches, such as the Bloomberg 100 Index Futures, and continued volume growth provide a compelling growth narrative, yet the elevated valuation and high recent volatility suggest caution. Investors should weigh the upside from market expansion against the risk of price correction given the overvalued metrics.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Price hovering near short‑term resistance with bullish MACD momentum
- Elevated valuation relative to peers
- Increasing trading volume supporting near‑term liquidity
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- Strong revenue growth and expanding market share
- Launch of new Bloomberg index futures broadening product suite
- Low leverage and solid cash generation
Long Term
> 3 yearsNeutral
Model confidence: 6/10
Key Factors
- Sustained growth prospects tempered by high valuation multiples
- Stable regulatory environment for exchange operations
- Low beta indicating limited systematic risk over the long horizon
Key Metrics & Analysis
Financial Health
Revenue Growth13.00%
Profit Margin8.64%
P/E Ratio32.4
ROE16.83%
ROA7.03%
Debt/Equity2.13
P/B Ratio3.9
Op. Cash Flow$217.5M
Free Cash Flow$139.3M
Industry P/E17.7
Technical Analysis
TrendNeutral
RSI58.3
Support$35.43
Resistance$45.24
MA 20$39.34
MA 50$45.00
MA 200$43.34
MACDBullish
VolumeIncreasing
Fear & Greed Index88.2
Valuation
Fair Value$38.61
Target Price$51.20
Upside/Downside17.11%
GradeOvervalued
TypeBlend
Risk Assessment
Beta0.64
Volatility60.14%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.